Literature DB >> 23959851

Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.

Sibel Bozdağ Pehlivan1.   

Abstract

Neurodegenerative disorders are becoming prevalent with the increasing age of the general population. A number of difficulties have emerged for the potential treatment of neurodegenerative diseases, as these disorders may be multi systemic in nature. Due to limitations regarding the blood brain barrier (BBB) structure, efflux pumps and metabolic enzyme expression, conventional drug delivery systems do not provide efficient therapy for neurodegenerative disorders. Nanotechnology can offer impressive improvement of the neurodegenerative disease treatment by using bio-engineered systems interacting with biological systems at a molecular level. This review focuses on the nano-enabled system applications for the treatment and diagnosis of neurodegenerative diseases, in particular Alzheimer’s, Parkinson’s and Prion diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23959851     DOI: 10.1007/s11095-013-1156-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  110 in total

Review 1.  Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease.

Authors:  C Soto
Journal:  Mol Med Today       Date:  1999-08

Review 2.  Improving the transport of chemotherapeutic drugs across the blood-brain barrier.

Authors:  Andrea Orthmann; Iduna Fichtner; Reiner Zeisig
Journal:  Expert Rev Clin Pharmacol       Date:  2011-07       Impact factor: 5.045

3.  Recent perspectives on nanoneuroprotection & nanoneurotoxicity.

Authors:  Hari Shanker Sharma; Aruna Sharma
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-02       Impact factor: 4.388

4.  Cytotoxicity of single-walled carbon nanotubes on PC12 cells.

Authors:  Jingyun Wang; Pingping Sun; Yongming Bao; Jiwen Liu; Lijia An
Journal:  Toxicol In Vitro       Date:  2010-11-19       Impact factor: 3.500

Review 5.  Biopharmaceutical drug targeting to the brain.

Authors:  William M Pardridge
Journal:  J Drug Target       Date:  2010-04       Impact factor: 5.121

6.  Transport of a caspase inhibitor across the blood-brain barrier by chitosan nanoparticles.

Authors:  Müge Yemişci; Yasemin Gürsoy-Özdemir; Seçil Caban; Ebru Bodur; Yılmaz Capan; Turgay Dalkara
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

Review 7.  Advances in the treatment of neurodegenerative disorders employing nanotechnology.

Authors:  Girish Modi; Viness Pillay; Yahya E Choonara
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 8.  Nanoparticle and other metal chelation therapeutics in Alzheimer disease.

Authors:  Gang Liu; Matthew R Garrett; Ping Men; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Biochim Biophys Acta       Date:  2005-09-25

Review 9.  Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's disease.

Authors:  Richard A Awad
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

10.  Nanosized zinc oxide particles induce neural stem cell apoptosis.

Authors:  Xiaoyong Deng; Qixia Luan; Wenting Chen; Yanli Wang; Minghong Wu; Haijiao Zhang; Zheng Jiao
Journal:  Nanotechnology       Date:  2009-02-24       Impact factor: 3.874

View more
  16 in total

Review 1.  3D in vitro modeling of the central nervous system.

Authors:  Amy M Hopkins; Elise DeSimone; Karolina Chwalek; David L Kaplan
Journal:  Prog Neurobiol       Date:  2014-11-22       Impact factor: 11.685

Review 2.  GABA-containing liposomes: neuroscience applications and translational perspectives for targeting neurological diseases.

Authors:  Marco Antônio Peliky Fontes; Gisele Cristiane Vaz; Thais Zielke Dias Cardoso; Mariana Flávia de Oliveira; Maria José Campagnole-Santos; Robson Augusto Souza Dos Santos; Neeru M Sharma; Kaushik P Patel; Frédéric Frézard
Journal:  Nanomedicine       Date:  2017-12-24       Impact factor: 5.307

3.  An in vitro Blood-brain Barrier Model to Study the Penetration of Nanoparticles.

Authors:  Sezin Aday; Wen Li; Jeffrey M Karp; Nitin Joshi
Journal:  Bio Protoc       Date:  2022-02-20

4.  Delivery strategies for cell-based therapies in the brain: overcoming multiple barriers.

Authors:  Olivia M Turk; Ryan C Woodall; Margarita Gutova; Christine E Brown; Russell C Rockne; Jennifer M Munson
Journal:  Drug Deliv Transl Res       Date:  2021-10-30       Impact factor: 5.671

5.  RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer.

Authors:  Chan Feng; Xiaoyan Li; Chunyan Dong; Xuemei Zhang; Xie Zhang; Yong Gao
Journal:  Drug Des Devel Ther       Date:  2015-08-11       Impact factor: 4.162

Review 6.  The janus facet of nanomaterials.

Authors:  Julianna Kardos; Katalin Jemnitz; István Jablonkai; Attila Bóta; Zoltán Varga; Júlia Visy; László Héja
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

7.  Preparation of a liposomal delivery system and its in vitro release of rapamycin.

Authors:  Zhi-Lin Miao; Ying-Jie Deng; Hong-Yang DU; Xu-Bin Suo; Xiao-Yu Wang; Xiao Wang; Li Wang; Li-Jie Cui; Na Duan
Journal:  Exp Ther Med       Date:  2015-01-22       Impact factor: 2.447

8.  Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.

Authors:  Heba Asem; Ying Zhao; Fei Ye; Åsa Barrefelt; Manuchehr Abedi-Valugerdi; Ramy El-Sayed; Ibrahim El-Serafi; Khalid M Abu-Salah; Jörg Hamm; Mamoun Muhammed; Moustapha Hassan
Journal:  J Nanobiotechnology       Date:  2016-12-19       Impact factor: 10.435

Review 9.  Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment.

Authors:  Stephanie Andrade; Maria João Ramalho; Maria do Carmo Pereira; Joana A Loureiro
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

Review 10.  Current Strategies for Brain Drug Delivery.

Authors:  Xiaowei Dong
Journal:  Theranostics       Date:  2018-02-05       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.